DK438688D0 - Kontraceptivt implant - Google Patents

Kontraceptivt implant

Info

Publication number
DK438688D0
DK438688D0 DK438688A DK438688A DK438688D0 DK 438688 D0 DK438688 D0 DK 438688D0 DK 438688 A DK438688 A DK 438688A DK 438688 A DK438688 A DK 438688A DK 438688 D0 DK438688 D0 DK 438688D0
Authority
DK
Denmark
Prior art keywords
contraceptive implant
implant
contraceptive
locally
release
Prior art date
Application number
DK438688A
Other languages
English (en)
Other versions
DK438688A (da
DK173166B1 (da
Inventor
Hendrik De Nijs
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19850428&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK438688(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of DK438688D0 publication Critical patent/DK438688D0/da
Publication of DK438688A publication Critical patent/DK438688A/da
Application granted granted Critical
Publication of DK173166B1 publication Critical patent/DK173166B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DK198804386A 1987-08-08 1988-08-05 Kontraceptivt implant DK173166B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8701868 1987-08-08
NL8701868 1987-08-08

Publications (3)

Publication Number Publication Date
DK438688D0 true DK438688D0 (da) 1988-08-05
DK438688A DK438688A (da) 1989-02-09
DK173166B1 DK173166B1 (da) 2000-02-28

Family

ID=19850428

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198804386A DK173166B1 (da) 1987-08-08 1988-08-05 Kontraceptivt implant

Country Status (18)

Country Link
US (3) US4957119A (da)
EP (1) EP0303306B1 (da)
JP (1) JP2571831B2 (da)
KR (1) KR950008763B1 (da)
CN (1) CN1024753C (da)
AT (1) ATE86484T1 (da)
AU (1) AU603475B2 (da)
CA (1) CA1309949C (da)
DE (2) DE3879031T2 (da)
DK (1) DK173166B1 (da)
ES (1) ES2054784T3 (da)
FI (1) FI93421C (da)
IE (1) IE61730B1 (da)
MX (1) MX9203817A (da)
NL (1) NL980027I2 (da)
NZ (1) NZ225399A (da)
PT (1) PT88220B (da)
ZA (1) ZA885034B (da)

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114719A (en) * 1987-04-29 1992-05-19 Sabel Bernhard A Extended drug delivery of small, water-soluble molecules
US5156164A (en) * 1988-10-13 1992-10-20 Leveen Harry H Iodine contraceptive sponge
BE1002600A3 (fr) * 1988-11-23 1991-04-09 Wildemeersch Dirk Dispositif intra-uterin perfectionne.
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
WO1993017662A1 (en) * 1992-03-02 1993-09-16 Daratech Pty. Ltd. Improved implants
ES2150427T3 (es) * 1992-06-02 2000-12-01 Bard Inc C R Procedimiento y dispositivo de implante para el suministro de farmacos a largo plazo.
US5368588A (en) * 1993-02-26 1994-11-29 Bettinger; David S. Parenteral fluid medication reservoir pump
US5443461A (en) * 1993-08-31 1995-08-22 Alza Corporation Segmented device for simultaneous delivery of multiple beneficial agents
US5681817A (en) 1994-02-04 1997-10-28 The Medical College Of Hampton Roads Treatment of ovarian estrogen dependent conditions
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
DE19539361A1 (de) * 1995-10-23 1997-04-24 Basf Ag Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung
US5733565A (en) * 1996-02-23 1998-03-31 The Population Council, Center For Biomedical Research Male contraceptive implant
CN1088993C (zh) * 1996-10-11 2002-08-14 上海市计划生育科学研究所 含孕二烯酮的长效皮下避孕埋植剂
US6203813B1 (en) 1997-01-13 2001-03-20 Lance L. Gooberman Pharmaceutical delivery device and method of preparation therefor
IL123813A0 (en) * 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
DE19744135C1 (de) * 1997-09-29 1999-03-25 Schering Ag Beschichtete medizinische Implantate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
JP2002513690A (ja) 1998-05-01 2002-05-14 エフイ−アイ エンタープライジズ，リミティド 制御放出デバイスの射出成形製造方法
US6117441A (en) * 1998-07-02 2000-09-12 The Population Council, Inc. Silicone core long term androgen delivery implant
JP2002520346A (ja) * 1998-07-17 2002-07-09 ファルマシア・アンド・アップジョン・カンパニー 避妊用皮下メドロキシプロゲステロンアセタート
US6063395A (en) * 1998-11-12 2000-05-16 Leiras Oy Drug delivery device especially for the delivery of progestins and estrogens
US6117442A (en) * 1998-11-12 2000-09-12 Leiras Oy Drug delivery device, especially for the delivery of androgens
US6217895B1 (en) 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
CA2267743C (en) * 1999-03-30 2011-07-26 Robert F. Casper Low dose estrogen interrupted hormone replacement therapy
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
MXPA03001147A (es) * 2000-08-23 2003-10-06 Akzo Nobel Nv Nueva formulacion de ester de testosterona para uso humano.
EP1545705A4 (en) 2000-11-16 2010-04-28 Microspherix Llc FLEXIBLE AND / OR ELASTIC BRACHYTHERAPY SEED OR STRAND
AU2002305079B8 (en) 2001-05-11 2006-05-25 Ortho-Mcneil Pharmaceutical, Inc. Immune modulation device for use in animals
RU2347570C2 (ru) 2001-07-02 2009-02-27 Н.В.Органон Тетрагидрохинолиновые производные
CN1289064C (zh) * 2001-08-31 2006-12-13 先灵有限责任公司 药物输送体系
NZ531375A (en) 2001-09-04 2005-06-24 Akzo Nobel Nv Glycine-substituted thieno [2,3-d]pyrimidines with combined LH and FSH agonistic activity may be used to treat fertility disorders
TWI228508B (en) 2001-09-04 2005-03-01 Akzo Nobel Nv Thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity
JP2005522418A (ja) * 2002-01-24 2005-07-28 スマート ドラッグ システムズ インコーポレイティド 徐放性医薬組成物
CN1652799A (zh) * 2002-03-11 2005-08-10 詹森药业有限公司 只用抑制硫酸酯酶的孕激素的避孕给药方案
TWI297685B (en) 2002-04-04 2008-06-11 Organon Nv Non-steroidal progesterone receptor modulators
CN1658836A (zh) * 2002-05-07 2005-08-24 控制传输系统公司 形成药物传递装置的方法
US8871241B2 (en) * 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
PT2561860T (pt) * 2002-05-31 2018-05-08 Titan Pharmaceuticals Inc Dispositivo polimérico implantável para a libertação prolongada de buprenorfina
MXPA05002294A (es) * 2002-08-28 2005-09-12 Casper Robert Regimen de sustitucion de estrogeno.
MXPA05004929A (es) 2002-11-07 2005-08-18 Akzo Nobel Nv Indoles utiles en el tratamiento de enfermedades relacionadas a receptor de androgeno.
TWI322012B (en) 2002-12-20 2010-03-21 Organon Nv Tetrahydroquinoline derivatives
TWI306855B (en) 2002-12-20 2009-03-01 Organon Nv Tetrahydroquinoline derivatives
CA2520613C (en) 2003-03-31 2012-12-04 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of dopamine agonist
US7833545B2 (en) 2003-04-29 2010-11-16 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
TWI336627B (en) 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
WO2004110400A2 (en) * 2003-05-30 2004-12-23 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of nalmefene
EP1643946A2 (en) * 2003-06-20 2006-04-12 Viral Genomix, Inc. Compositions for and methods for treating hiv
WO2005070444A2 (en) * 2004-01-13 2005-08-04 Vasogenix Pharmaceuticals, Inc. Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same
EP1703895A2 (en) * 2004-01-13 2006-09-27 Vasogenix Pharmaceuticals, Inc. Controlled release cgrp delivery composition for cardiovascular and renal indications
CA2552758A1 (en) * 2004-01-13 2005-08-04 Vasogenix Pharmaceuticals, Inc. Methods for treating acute myocardial infarction by administering calcitonin gene related peptide and compositions containing the same
TWI434676B (zh) * 2004-03-19 2014-04-21 Merck Sharp & Dohme 可用ｘ射線看出之藥物遞送裝置
TW200531977A (en) 2004-03-25 2005-10-01 Akzo Nobel Nv Progesterone receptor modulators
TW200602317A (en) 2004-04-23 2006-01-16 Akzo Nobel Nv Novel androgens
ATE372772T1 (de) † 2004-07-13 2007-09-15 Schering Oy Retardiertes freigabesystem mit kontrollierter initialabgabe
EP2594259A1 (en) 2004-08-04 2013-05-22 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
AU2006259368A1 (en) 2005-06-15 2006-12-28 Hydra Biosciences, Inc. Modulators of sperm hypermotility and uses thereof
EP1743638A1 (en) 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. Pharmaceutical formulations of substituted pyrazoline compounds
CA2670821C (en) 2006-08-09 2012-05-15 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
US7989442B2 (en) 2006-09-27 2011-08-02 N.V. Organon Progesterone receptor modulators
CN101209238B (zh) * 2006-12-27 2012-05-09 辽宁省计划生育科学研究院 含孕二烯酮的生物降解型长效皮下避孕埋植剂及其制备
CA2683610C (en) 2007-04-23 2013-01-08 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
US8063037B2 (en) 2007-05-07 2011-11-22 N. V. Organon Progesterone receptor modulators
CN101130057B (zh) * 2007-07-06 2011-04-27 复旦大学 胸腺五肽长效植入剂及其制备方法
AR066166A1 (es) 2007-09-21 2009-07-29 Organon Nv Sistema de suministro de droga
US20100303841A1 (en) * 2007-11-27 2010-12-02 Nira Hochman Adjuvant
CA2709712C (en) 2007-12-20 2016-05-10 Surmodics Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
MX378797B (es) 2009-09-28 2025-03-10 Intarcia Therapeutics Inc Establecimiento y/o terminacion rapidos de suministro de estado estable sustancial de farmaco.
WO2011079232A1 (en) * 2009-12-23 2011-06-30 Psivida Us, Inc. Sustained release delivery devices
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
AR089765A1 (es) * 2012-01-23 2014-09-17 Bayer Oy Un sistema para el suministro de un farmaco
USD718435S1 (en) 2012-05-30 2014-11-25 Medicines360 Intrauterine insertion device
WO2014121333A1 (en) 2013-02-06 2014-08-14 Sillender Mark Embryo transfer catheter and method
US10154856B2 (en) 2013-02-06 2018-12-18 Mark SILLENDER Therapeutic substance transfer catheter and method
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
US10596103B2 (en) 2013-12-11 2020-03-24 Merek Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
WO2016149561A1 (en) * 2015-03-17 2016-09-22 Oak Crest Institute Of Science Subdermal implants for the sustained delivery of water-soluble drugs
CN113598842A (zh) 2015-06-03 2021-11-05 因塔西亚制药公司 植入物放置和移除系统
KR102574993B1 (ko) 2016-05-16 2023-09-06 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
WO2018064556A1 (en) 2016-09-29 2018-04-05 Gesea Biosciences Inc. Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
WO2018129058A1 (en) 2017-01-03 2018-07-12 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
US11571328B2 (en) 2018-04-09 2023-02-07 Medicines360 IUD insertion devices
WO2019226519A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
WO2019222856A1 (en) 2018-05-24 2019-11-28 Nureva Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
AU2019275406B2 (en) * 2018-05-24 2024-11-14 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
US20200261258A1 (en) 2019-02-19 2020-08-20 Medicines360 Devices, systems, methods and kits for insertion and removal of iuds
BR102020007749A2 (pt) 2020-04-17 2021-11-03 Edson Luiz Peracchi Implante subcutâneo reabsorvível de longa duração com liberação controlada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da endometriose
BR102020010923A2 (pt) 2020-05-29 2021-12-14 Luiz Peracchi Edson Implante subcutâneo reabsorvível de longa duração com liberação prolongada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da insuficiência adrenal crônica ou hipocortisolismo
BR102020013862A2 (pt) 2020-07-07 2022-01-18 Edson Luiz Peracchi Implante subcutâneo reabsorvível de longa duração com liberação sustentada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da doença de parkinson
US20240165064A1 (en) 2021-03-29 2024-05-23 Edson Luiz Peracchi Long-lasting resorbable subcutaneous implant with prolonged release of pre-concentrated pharmacologically active substance in polymer for the treatment of hypothyroidism, and method
WO2022231930A1 (en) 2021-04-26 2022-11-03 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
CN113209050A (zh) * 2021-05-14 2021-08-06 浙江恒冀制药有限责任公司 基于生物相容性聚合物的长效体内皮埋或内植缓释制剂
US20230233455A1 (en) * 2022-01-24 2023-07-27 Celanese Eva Performance Polymers Llc Method for Prohibiting and/or Treating an Eye Condition
US12544256B2 (en) 2022-09-16 2026-02-10 Medicines360 IUD removal devices, and related methods and kits
WO2024184356A1 (en) * 2023-03-06 2024-09-12 Institut National de la Santé et de la Recherche Médicale Miniaturized implants for the inner ear
GB202401392D0 (en) 2024-02-02 2024-03-20 Imphatec Ltd Implant for delivery of a drug
WO2025174767A1 (en) * 2024-02-13 2025-08-21 Biraj Investments, Llc Highly loaded implantable devices with high tensile strength for drug delivery

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903880A (en) * 1972-08-17 1975-09-09 Alza Corp Intrauterine device for managing the reproductive process
US3926188A (en) * 1974-11-14 1975-12-16 Alza Corp Laminated drug dispenser
US4582052A (en) * 1982-03-23 1986-04-15 Repromed, Inc. Povidone-iodine dispensing fiber
NZ200564A (en) * 1982-05-10 1987-03-06 Ahi Operations Ltd Device for slowly releasing chemicals into body cavities of animals
US4601714A (en) * 1983-07-07 1986-07-22 Burnhill Michael S Vaginal device
US4629621A (en) * 1984-07-23 1986-12-16 Zetachron, Inc. Erodible matrix for sustained release bioactive composition
EP0180264A1 (en) * 1984-10-12 1986-05-07 Akzo N.V. Release system for two or more active substances
US4720384A (en) * 1985-05-03 1988-01-19 E. I. Du Pont De Nemours And Company Manufacture of hollow fine tubular drug delivery systems
US4673565A (en) * 1985-05-03 1987-06-16 E. I. Du Pont De Nemours And Company Pharmaceutical compositions containing hollow fine tubular drug delivery systems

Also Published As

Publication number Publication date
AU2044988A (en) 1989-03-02
JP2571831B2 (ja) 1997-01-16
AU603475B2 (en) 1990-11-15
KR950008763B1 (en) 1995-08-08
DK438688A (da) 1989-02-09
US5150718A (en) 1992-09-29
ATE86484T1 (de) 1993-03-15
FI883594L (fi) 1989-02-09
MX9203817A (es) 1992-08-01
FI93421C (fi) 1995-04-10
NL980027I2 (nl) 1999-02-01
PT88220B (pt) 1995-03-01
HK1002020A1 (en) 1998-07-24
IE882118L (en) 1989-02-08
US4957119A (en) 1990-09-18
DE19975054I2 (de) 2000-04-13
NL980027I1 (nl) 1998-12-01
JPS6470410A (en) 1989-03-15
FI883594A0 (fi) 1988-08-01
CN1031323A (zh) 1989-03-01
PT88220A (pt) 1989-06-30
ZA885034B (en) 1989-03-29
DE3879031T2 (de) 1993-06-24
KR890003360A (ko) 1989-04-14
DK173166B1 (da) 2000-02-28
IE61730B1 (en) 1994-11-30
CA1309949C (en) 1992-11-10
EP0303306B1 (en) 1993-03-10
CN1024753C (zh) 1994-06-01
ES2054784T3 (es) 1994-08-16
FI93421B (fi) 1994-12-30
US5088505A (en) 1992-02-18
EP0303306A1 (en) 1989-02-15
DE3879031D1 (de) 1993-04-15
NZ225399A (en) 1990-09-26

Similar Documents

Publication Publication Date Title
DE19975054I2 (de) Kontrazeptives Implantat
DE3877174D1 (de) Bezugssystem zur implantation von kondylaeren knie-totalprothesen.
DE3881363D1 (de) Implantierbare prothetische vorrichtung.
TW224942B (da)
DE3864941D1 (de) Mechanische penisprothese.
ES2024634B3 (es) Protesis de articulacion.
NO881938D0 (no) Ortopedisk skinne.
DE68906771D1 (de) Verankerungsvorrichtung fuer knieprothese.
DE3869446D1 (de) Desodorierungsmittel.
IT1242170B (it) Composizione adesiva stabilizzante per protesi dentarie.
DE3887839D1 (de) Trennmittelzusammensetzung.
ATE81771T1 (de) Bolusfoermige vorrichtung zur gesteuerten wirkstofffreisetzung.
IT9048524A0 (it) Composizione adesiva stabilizzante per protesi dentarie.
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
DE68909239D1 (de) Implantierbare Prothese.
NL194747B (nl) Preparaat voor de afgifte van diltiazem.
FR2654922B1 (fr) Implant de remplissage penien.
MX152874A (es) Mejoras en dispositivo de acoplamiento ortopedico
ES510927A0 (es) "un procedimiento para la preparacion de esteres de mercapto acil-carnitina".
NO883443L (no) Loesbar mekanisk kobling for strekkopptagende forankring.
DE3868432D1 (de) Automatisches steuerungsverfahren fuer den schussfadeneintrag.
DE69021536D1 (de) Zahnimplantatsystem.
IE902286L (en) Use of isoxazolin-3-one derivatives as antidepressants
BR9002002A (pt) Acelerador automatico atuado por pressao
NO870417D0 (no) Oppdriftslegemer for boelgedempere.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
CTFF Application for supplementary protection certificate (spc) filed

Free format text: PRODUCT NAME: ETONOGESTREL; NAT. REGISTRATION NO/DATE: 30379 19990312; FIRST REGISTRATION: NL 2116819990825

Spc suppl protection certif: CA 2000 00008

Filing date: 20000411

PUP Patent expired
CTFG Supplementary protection certificate (spc) issued

Free format text: PRODUCT NAME: ETONOGESTREL; NAT. REGISTRATION NO/DATE: 30379 19990312;FIRST REGISTRATION: NL 21168 19989825

Spc suppl protection certif: CA 2000 00008

Filing date: 20000411

Extension date: 20130805